The Gross Margin of Sorrento Therapeutics Inc (SRNE) is 46.66%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2022-12-31 | 46.66% |
| 2021-12-31 | 75.43% |
| 2020-12-31 | 75.25% |
| 2019-12-31 | 61.15% |
| 2018-12-31 | 66.51% |
| 2017-12-31 | 97.43% |
| 2016-12-31 | 90.24% |
| 2015-12-31 | 56.52% |
| 2014-12-31 | 47.37% |
| 2013-12-31 | 100.00% |